Managing Mental Illness After COVID-19 Infection (eBook)
456 Seiten
Wiley (Verlag)
978-1-394-22760-0 (ISBN)
A concise, practical guide to the mental health effects of COVID-19 and its treatments
Managing Mental Illness After COVID-19 Infection is a resource for people affected by COVID-19 and their loved ones. As the long-term effects, especially the psychiatric effects, evolve and become more common, people are increasingly searching for answers. This book reviews presentations and treatments for mental illnesses post-COVID-19. Readers will learn about the use of medications, supplements, and behavioral interventions to address these conditions.
This engaging and practical book includes numerous tables and other illustrations for easy reference. It provides enough medical detail for patients and their caregivers to better understand the symptoms they may experience, as well as the best ways to investigate and treat those symptoms. However, it is not too complex for the general reader, making it perfect as a standalone book for patients and their families.
- Learn how and why many people struggle with mental illness following COVID-19 infection
- Discover what your symptoms may indicate and get advice on how to pursue diagnosis and treatment
- Find a doctor who can understand and manage the mental and behavioral consequences of COVID-19
- Get up to speed on the psychiatric and psychosocial effects of COVID-19 infection
This is an excellent resource for the public, policymakers, clinicians, counselors, social workers, and behavioral health coaches that could benefit from the latest research on the psychiatric effects of COVID-19.
Stephanie A. Collier, MD, MPH, is the director of education in the Division of Geriatric Psychiatry, associate director of the Department of Postgraduate and Continuing Education, and consulting psychiatrist for the Metabolic and Mental Health Program at McLean Hospital. She is an instructor in psychiatry at Harvard Medical School. Dr. Collier is the Editor-in-Chief of the Carlat Geriatric Psychiatry Report.
A concise, practical guide to the mental health effects of COVID-19 and its treatments Managing Mental Illness After COVID-19 Infection is a resource for people affected by COVID-19 and their loved ones. As the long-term effects, especially the psychiatric effects, evolve and become more common, people are increasingly searching for answers. This book reviews presentations and treatments for mental illnesses post-COVID-19. Readers will learn about the use of medications, supplements, and behavioral interventions to address these conditions. This engaging and practical book includes numerous tables and other illustrations for easy reference. It provides enough medical detail for patients and their caregivers to better understand the symptoms they may experience, as well as the best ways to investigate and treat those symptoms. However, it is not too complex for the general reader, making it perfect as a standalone book for patients and their families. Learn how and why many people struggle with mental illness following COVID-19 infection Discover what your symptoms may indicate and get advice on how to pursue diagnosis and treatment Find a doctor who can understand and manage the mental and behavioral consequences of COVID-19 Get up to speed on the psychiatric and psychosocial effects of COVID-19 infection This is an excellent resource for the public, policymakers, clinicians, counselors, social workers, and behavioral health coaches that could benefit from the latest research on the psychiatric effects of COVID-19.
List of Abbreviations
Chapter 1
- post‐traumatic stress disorder (PTSD)
- Inter‐Agency Standing Committee (IASC)
- mental health and psychosocial support (MHPSS)
- psychological first aid (PFA)
- World Health Organization (WHO)
Chapter 2
- Equal Employment Opportunity Commission (EEOC)
- exposure and response prevention (ERP) [Table 2.1]
- intensive care unit (ICU)
- magnetic resonance imaging (MRI)
- Montreal Cognitive Assessment (MoCA)
- Occupational Safety and Health Administration (OSHA)
- polymerase chain reaction (PCR)
- positron emission tomography (PET)
- post‐traumatic stress disorder (PTSD)
- St. Louis University Mental Status Examination (SLUMS)
Chapter 3
- acceptance and commitment therapy (ACT)
- central nervous system (CNS)
- cognitive behavioral therapy (CBT)
- Emergency Use Authorizations (EUA)
- Food and Drug Administration (FDA)
- magnetic resonance imaging (MRI)
- mind‐body therapies (MBT)
- mindfulness‐based stress reduction (MBSR) [Figure 3.1]
- mindfulness‐based cognitive therapy (MBCT) [Figure 3.1]
- mindfulness‐based relapse prevention (MBRP) [Figure 3.1]
- N‐Acetylcysteine (NAC)
- National Institute of Health (NIH)
- post‐traumatic stress disorder (PTSD)
- problem solving therapy (PST)
- religion and spirituality (R/S)
- ribonucleic acid (RNA) viruses
- severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- Sudarshan Kriya Yoga (SKY)
- transcranial magnetic stimulation (TMS)
- Whole Health System Approach (HEALTH)
Chapter 4
- acute respiratory distress syndrome (ARDS)
- Age‐Friendly Health Systems (AFHS)
- Confusion Assessment Method (CAM)
- Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center
- Differentiate Aging and Dementia (AD8)
- Food and Drug Administration (FDA)
- General Anxiety Disorder‐7 (GAD‐7)
- Hospital Elder Life Program (HELP)
- Institute for Healthcare Improvement (IHI)
- intensive care unit (ICU)
- Montreal Cognitive Assessment (MoCA)
- Pain, Agitation, Delirium, Immobility, and Sleep (PADIS) guidelines
- Patient Health Questionnaire‐9 (PHQ‐9)
- post‐intensive care syndrome (PICS)
- post‐traumatic stress disorder (PTSD)
- Primary Care PTSD Screen for DSM‐5 (PC‐PTSD‐5)
Chapter 5
- acceptance and commitment therapy (ACT)
- cognitive behavioral therapy (CBT)
- electroconvulsive therapy (ECT)
- major depressive disorder (MDD)
- mindfulness‐based cognitive therapy (MBCT)
- Patient Health Questionnaire‐2 (PHQ‐2)
- primary care physician (PCP)
- serotonin‐norepinephrine reuptake inhibitors (SNRIs)
- selective serotonin reuptake inhibitors (SSRIs)
- severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- transcranial magnetic stimulation (TMS)
Chapter 6
- acceptance and commitment therapy (ACT)
- cognitive behavioral therapy (CBT)
- entromedial prefrontal cortex (VMPFc) [Figure 6.1]
- exposure and response prevention (ERP)
- generalized anxiety disorder (GAD)
- obsessive‐compulsive disorder (OCD)
- orbitofrontal cortex (OFC) [and Figure 6.1]
- periaqueductal gray (PAG) [Figure 6.1]
- post‐traumatic stress disorder (PTSD)
- prefrontal cortex (PFC)
- selective serotonin reuptake inhibitors (SSRI)
- ventral tegmental area (VTA) [Figure 6.1]
Chapter 7
- adverse childhood experiences (ACE)
- neuroleptic malignant syndrome (NMS)
- phencyclidine (PCP)
- post‐traumatic stress disorder (PTSD)
Chapter 8
- adenosine triphosphate (ATP)
- angiotensin‐converting enzyme‐2 (ACE2)
- aspirin (ASA)
- beats per minute (bpm)
- CC chemokine receptor 5 (CCR5)
- chronic fatigue syndrome (CFS)
- Centers for Disease Control and Prevention (CDC)
- Coenzyme Q10 (CoQ10)
- cognitive behavioral therapy (CBT)
- Epstein‐Barr virus (EBV)
- G‐protein coupled receptors (GPCRs)
- graded exercise therapy (GET)
- high‐efficiency particulate air (HEPA)
- human herpes virus 6 (HHV‐6)
- human herpes virus 7 (HHV‐7)
- human immunodeficiency virus (HIV)
- hyperbaric oxygen therapy (HBOT)
- hyperbaric oxygen therapy for Long COVID syndrome (HOT‐LoCO)
- Janus kinase (JAK) inhibitor
- mast cell activation syndrome (MCAS)
- minimum efficiency reporting value (MERV)
- monoclonal antibodies (mABs)
- multisystem inflammatory syndrome in children (MIS‐C)
- myalgic encephalomyelitis (ME)
- myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS)
- N‐acetylcysteine (NAC)
- National Public Radio (NPR)
- nicotinamide adenine dinucleotide (NAD+)
- nicotinic acetylcholine receptors (nAChRs)
- nitric oxide (NO)
- obsessive‐compulsive disorder (OCD)
- polymerase chain reaction (PCR) test
- post‐exertional malaise (PEM)
- postural orthostatic tachycardia syndrome (POTS)
- randomized controlled trial (RCTs)
- rheumatoid arthritis (RA)
- ribonucleic acid (RNA)
- selective serotonin reuptake inhibitors (SSRIs)
- severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- therapies for Long COVID (TLC)
- transcranial direct current stimulation (tDCS)
- transcutaneous vagus nerve stimulation (tVNS)
- UHN Emergency Department (ED)
- University Health Network (UHN) News
- vascular endothelial growth factor (VEGF)
- World Health Organization (WHO)
Chapter 9
- 5‐hydroxyindoleacetic acid (5‐HIAA)
- acute respiratory distress syndrome (ARDS)
- Centers for Disease Control and Prevention (CDC)
- cerebrospinal fluid (CSF)
- chronic obstructive pulmonary disease (COPD)
- Diagnostic and Statistical Manual (DSM)
- electrocardiogram (EKG or ECG)
- Food and Drug Administration (FDA)
- Edinburgh Postnatal Depression Scale (EPDS)
- human chorionic gonadotropin (hCG)
- intensive care unit (ICU)
- intramuscular (IM)
- intravenous (IV)
- neonatal intensive care unit (NICU)
- Patient Health Questionairre‐9 (PHQ‐9)
- post‐traumatic stress disorder (PTSD)
- selective serotonin reuptake inhibitors (SSRIs)
- traumatic brain injury (TBI)
- urinary tract infection (UTI)
- World Health Organization (WHO)
Chapter 10
- American Academy of Physical Medicine and Rehabilitation (AAPM&R)
- American College of Obstetrics and Gynecologists (ACOG)
- attention deficit hyperactivity disorder (ADHD)
- Center for Disease Control and Prevention (CDC)
- cognitive behavioral therapy (CBT)
- Edinburgh Postnatal Depression Scale (EPDS)emergency room (ER)
- gastrointestinal (GI)
- human chorionic gonadotropin (hCG)
- intensive care unit (ICU)
- Maternal COVID‐19‐related Prenatal Exposure (MOM‐COPE)
- messenger ribonucleic acid (mRNA)
- neonatal intensive care unit (NICU)
- Patient Health Questionairre‐9 (PHQ‐9)
- postural orthostatic tachycardia syndrome (POTS)
- respiratory syncytial virus (RSV)
- selective serotonin reuptake inhibitors (SSRIs)
- World Health Organization (WHO)
Chapter 11
- American Academy of Physical Medicine and Rehabilitation (AAPM&R)
- anorexia nervosa (AN)
- attention deficit hyperactivity disorder (ADHD)
- Centers for Disease Control (CDC)
- central nervous system (CNS)
- child‐parent psychotherapy (CPP)
- cognitive behavioral therapy (CBT)
- DIR‐Floortime (Developmental, Individual‐differences, and Relationship‐based model)
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‐5TR)
- electroconvulsive therapy (ECT)
- gastrointestinal (GI)
- generalized anxiety disorder (GAD)
- Hungry, Angry, Lonely, Tired (HALT mnemonic)
- irritable bowel syndrome (IBS)
- obsessive‐compulsive disorder (OCD)
- parent‐child interaction therapy (PCIT)
- Patient‐Reported Outcomes Measurement Information System (PROMIS measures)
- Pediatric Symptom Checklist‐17 (PSC‐17)
- post‐traumatic stress disorder (PTSD)
- postural orthostatic tachycardia syndrome (POTS)
- respiratory syncytial virus (RSV)
- serotonin‐specific reuptake inhibitor (SSRI)
- trauma‐focused cognitive behavioral therapy (TF‐CBT)
Chapter 12
- generalized anxiety disorder...
| Erscheint lt. Verlag | 13.11.2024 |
|---|---|
| Sprache | englisch |
| Themenwelt | Geisteswissenschaften ► Psychologie |
| Sozialwissenschaften ► Pädagogik ► Sozialpädagogik | |
| Schlagworte | Covid-19 side effects • covid anxiety • long covid • long covid book • long covid depression • long covid symptoms • mental effects of covid • Mental health covid • mental illness covid • psychological effects of covid-19 • psychosocial effects of covid-19 |
| ISBN-10 | 1-394-22760-4 / 1394227604 |
| ISBN-13 | 978-1-394-22760-0 / 9781394227600 |
| Haben Sie eine Frage zum Produkt? |
EPUB (Adobe DRM)Größe: 1,6 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
